Abstract:Boron-dipyrromethene (BODIPY) dyes have aroused considerable interest in cancer theranostics over the past decade because of robust photochemical properties. Although a large number of BODIPY photosensitizers (PSs) containing heavy atoms have been reported, the development of heavy-atom-free BODIPY PSs for oncologic photodynamic therapy (PDT) has been limited mainly by the uncertainty in intersystem crossing (ISC) mechanisms, unbalanced phototoxic effectiveness and fluorescence quantum yields, and aggregation-caused quenching effects. In addition, the lack of extensive in vivo studies of heavy-atom-free BODIPY PSs continues to limit clinical application. Herein, novel heavy-atom-free BODIPY-phenoxazine triads (BDP-8/BDP-9) that generate efficient excited triplet states via radical pair intersystem crossing (RP-ISC) followed by triplet charge recombination were developed for use in fluorescence image-guided PDT. BDP-8/BDP-9 exhibited high molar absorption coefficients, prominent aggregation-induced emission, and excellent singlet oxygen generation capability upon light irradiation. The corresponding BODIPY nanoparticles (BDP-8/BDP-9 NPs) with bright red emission, considerable phototoxicity, and excellent tumor-targeting ability were simply prepared by encapsulating BDP-8/BDP-9 PSs in a polymeric matrix. More importantly, the results of both in vitro and in vivo experiments demonstrated the considerable potential of BDP-8 NPs for image-guided photodynamic cancer therapy. This study may inspire the development of potential BODIPY-based nanoagents for cancer theranostics.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.chemmater.1c02776.Experimental data; synthesis, nanoparticle preparation, photophysical measurements, and reactive oxygen species measurements of BDP-8/BDP-9; in vitro and in vivo studies of BDP-8/BDP-9 NPs; 1H and 13C NMR spectra of all compounds; UV–vis absorption and PL spectra; fluorescence images; computational details, calculated electronic transition energies; energy gap between single and triplet states; spin-orbit coupling constant; and intersystem crossing rate constant (PDF)This article has not yet been cited by other publications.

Photo‐Induced Disproportionation‐Mediated Photodynamic Therapy: Simultaneous Oxidation of Tetrahydrobiopterin and Generation of Superoxide Radicals

Synthesis of Hemoglobin Conjugated Polymeric Micelle: A ZnPc Carrier with Oxygen Self-Compensating Ability for Photodynamic Therapy.

The Photodynamic Agent Designed by Involvement of Hydrogen Atom Transfer for Enhancing Photodynamic Therapy

Supramolecular Photosensitizer Enables Oxygen-Independent Generation of Hydroxyl Radicals for Photodynamic Therapy.

An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers

Deciphering Oxygen‐Independent Augmented Photodynamic Oncotherapy by Facilitating the Separation of Electron‐Hole Pairs

The orthogonal α‐meso‐Linked bisBODIPY photosensitizers demonstrate effective two‐photon fluorescence imaging and photodynamic therapy

Molecular Engineering of Pure Superoxide Radical Photogenerator for Hypoxia-Tolerant Tumor Theranostics

Mitochondria-targeting BODIPY-loaded Micelles As Novel Class of Photosensitizer for Photodynamic Therapy

Rational design of type-I photosensitizer molecules for mitochondrion-targeted photodynamic therapy

Self‐Assembly Induced Photosensitization of Long‐Tailed Heavy‐Atom‐Free BODIPY Derivatives for Photodynamic Therapy

Molecular Design of Monochromophore-Based Bifunctional Photosensitizers for Simultaneous Ratiometric Oxygen Reporting and Photodynamic Cancer Therapy

Auto-Deactivation of BODIPY-Derived Type I Photosensitizer Post Photodynamic Therapy under Hypoxia.

Photoinduced Carbene for Effective Photodynamic Therapy Against Hypoxic Cancer Cells

The halogen effect of bis-truxene substituted BODIPY photosensitizers for potential photodynamic therapy

A Facile Supramolecular Strategy to Switch Photodynamic Pathway and Augment ROS Production of Sensitizers for Enhanced Tumor Therapy

Optimizing Mitochondrial-Targeting Groups of Positively-Charged BODIPY Nanoparticles for Enhanced Photodynamic Therapy

Lysosome directed red light photodynamic therapy using glycosylated iron-(III) conjugates of boron-dipyrromethene

Molecular engineering to elevate reactive oxygen species generation for synergetic damage on lipid droplets and mitochondria

Access to the Triplet Excited States of Heavy-Atom-Free Boron-Dipyrromethene Photosensitizers via Radical Pair Intersystem Crossing for Image-Guided Tumor-Targeted Photodynamic Therapy

Self-quenching synthesis of coordination polymer pre-drug nanoparticles for selective photodynamic therapy